- Home
- MKSI vs RGEN Comparison
MKSI vs RGEN Comparison
Compare MKSI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKSI
- RGEN
- Stock Information
- Founded
- MKSI 1961
- RGEN 1981
- Country
- MKSI United States
- RGEN United States
- Employees
- MKSI N/A
- RGEN N/A
- Industry
- MKSI Industrial Machinery/Components
- RGEN Medical/Dental Instruments
- Sector
- MKSI Industrials
- RGEN Health Care
- Exchange
- MKSI Nasdaq
- RGEN Nasdaq
- Market Cap
- MKSI N/A
- RGEN 7.6B
- IPO Year
- MKSI 1999
- RGEN N/A
- Fundamental
- Price
- MKSI $111.11
- RGEN $156.55
- Analyst Decision
- MKSI Strong Buy
- RGEN Buy
- Analyst Count
- MKSI 11
- RGEN 12
- Target Price
- MKSI $143.00
- RGEN $187.44
- AVG Volume (30 Days)
- MKSI 701.3K
- RGEN 470.1K
- Earning Date
- MKSI 02-05-2025
- RGEN 02-19-2025
- Dividend Yield
- MKSI 0.79%
- RGEN N/A
- EPS Growth
- MKSI N/A
- RGEN N/A
- EPS
- MKSI 0.45
- RGEN N/A
- Revenue
- MKSI $3,544,000,000.00
- RGEN $633,513,000.00
- Revenue This Year
- MKSI $0.41
- RGEN $2.28
- Revenue Next Year
- MKSI $8.06
- RGEN $9.88
- P/E Ratio
- MKSI $245.43
- RGEN N/A
- Revenue Growth
- MKSI N/A
- RGEN N/A
- 52 Week Low
- MKSI $97.54
- RGEN $113.50
- 52 Week High
- MKSI $147.40
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- MKSI 53.46
- RGEN 60.07
- Support Level
- MKSI $105.34
- RGEN $149.15
- Resistance Level
- MKSI $116.63
- RGEN $160.64
- Average True Range (ATR)
- MKSI 3.14
- RGEN 5.96
- MACD
- MKSI 0.50
- RGEN 0.91
- Stochastic Oscillator
- MKSI 61.53
- RGEN 79.57
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.